Cytokine Release Syndrome Manageable in Relapsed/Refractory Multiple Myeloma Treated With CAR-T Therapy
Researchers sought to analyze the occurrence and severity of cytokine release syndrome in patients with relapsed/refractory multiple myeloma who recieve CAR-T therapy.
